Skip to main content
. 2020 Sep 30;25(3):127–135. doi: 10.15430/JCP.2020.25.3.127

Figure 1. A simplified view of the biological mechanisms of non-steroidal anti-inflammatory drugs (NSAIDs) and COX2 selective inhibitors (COXIBs).

Figure 1

NSAIDs and COXIBs inhibit COX1/2 enzymes and block the synthesis of inflammatory prostaglandins, therefore inhibit the downstream tumor-promoting events, such as inflammation, cell proliferation, and angiogenesis, and prevent cancer initiation.